Skip to main content

Table 1 Demographic characteristics of 84 patients with staphylococcal PVGI

From: Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin

Population, n = 84

Remission

Failure

p

 

n = 63, (%)

n = 21, (%)

 

Age, mean ± SD

64.1 ± 11

67.8 ± 12

0.2

Diabetes mellitus

19 (30.1)

6 (28.5)

0.89

Body mass index, mean ± SD

25 ± 4.7

26 ± 4.3

0.46

Creatinine clearance < 60 ml/min

15 (23.8)

9 (42.8)

0.09

Immunodepression

11 (17.4)

4 (19.1)

0.86

Chronic obstructive pulmonary disease

14 (22.2)

8 (38.1)

0.15

Coronary disease

35 (55.5)

13 (61.9)

0.61

Aortic aneurysm

20 (31.7)

12 (57.1)

0.03

Presumed PVGI

7 (11.1)

1 (4.7)

0.39

Definite PVGI

56 (88.9)

20 (95.2)

0.39

Early definite PVGI (<4 months)

30 (47.6)

12 (57.1)

0.45

Late definite PVGI (> 4 months)

26 (41.2)

8 (38.1)

0.79

Extracavitary PVGI

31 (49.9)

6 (29.6)

0.07

Fever > 38°C

37 (58.7)

19 (90.5)

0.009

Fissuration/disruption

7 (11.1)

2 (9.5)

0.02

False aneurysm

9 (14.2)

2 (9.5)

0.6

White blood cells count (G/l)

11.196 ± 4.6

11.022 ± 3.48

0.88

Mean ± SD

Autologous vein

10 (15.8)

2 (9.5)

0.47

Arterial homo/allograft

20 (31.7)

4 (19)

0.26

New prosthesis

6 (9.5)

2 (9.5)

1

Debridement

16 (25.4)

8 (38.1)

0.26

Medical treatment (no surgery)

9 (9.5)

4 (19)

0.6

Adequate empirical antibiotherapy

60 (95.2)

19 (90.4)

0.42

New surgery

15 (23.8)

10 (47.6)

0.02

Rifampin combination

38 (60.3)

7 (33.3)

0.03

Admission to intensive care unit

21 (33.3)

14 (66.6)

0.007

Septic shock at initial presentation

7 (11.1)

8 (38.1)

0.005

Post-operative dialysis

0 (0)

4 (19)

0.001

Death related to PVGI

0 (0)

14 (66.6)

0.001

Death not related to PVGI

6 (9.5)

2 (9.5)

1

Median follow-up (interquartile) (days)

605 ± 406

621 ± 455

0.2

  1. PVGI: Prosthetic vascular graft infection. MSSA: Methicillin-susceptible Staphylococcus aureus; MRSA: Methicillin-resistant Staphylococcus aureus; CNS, Coagulase-negative staphylococci.